SCHEMBL179261

SCHEMBL179261

CC(C)(C)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4915083 1.00
Bromide SCHEMBL31035612 0.96 CYP2B6 (0.37)
SCHEMBL627257 0.96 CYP2B6 (0.42)
SCHEMBL1106426 0.96 CYP2B6 (0.42)
SCHEMBL23251538 0.96 CYP2B6 (0.37)
SCHEMBL24928774 0.96 CYP2B6 (0.42)
SCHEMBL24927970 0.96 CYP2B6 (0.42)
SCHEMBL23988087 0.96 CYP2B6 (0.42)
SCHEMBL24928198 0.96 CYP2B6 (0.42)
SCHEMBL24928097 0.96 CYP2B6 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3143 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509598-B2 Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent DONGWOO FINE-CHEM CO., LTD. (KR) 2025-12-30 US claimed
CN-113493628-B Quantum dot ink and preparation method of quantum dot film TCL科技集团股份有限公司 2023-06-23 CN claimed
CN-107207693-A Aqueous polyurethane dispersions 塔明克公司 2017-09-26 CN claimed
EP-1999114-B1 PYRAZOLES AS 11-BETA-HSD-1 HOFFMANN LA ROCHE (CH) 2015-07-22 EP claimed
EP-2295411-A1 Pyrazoles as 11-beta-hsd-1 F. Hoffmann-La Roche AG (CH) 2011-03-16 EP claimed
US-7728029-B2 Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase HOFFMANN-LA ROCHE INC. (US) 2010-06-01 US claimed
EP-1999114-A2 PYRAZOLES AS 11-BETA-HSD-1 F. Hoffmann-la Roche AG (CH) 2008-12-10 EP claimed
WO-2007107470-A2 PYRAZOLES AS 11-BETA-HSD-1 F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 WO claimed
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase ANDERSON KEVIN WILLIAM 2007-09-27 US claimed
US-20260021213-A1 METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT NIHON MEDI-PHYSICS CO., LTD. (JP) 2026-01-22 US disclosed
US-12509598-B2 Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent DONGWOO FINE-CHEM CO., LTD. (KR) 2025-12-30 US disclosed
US-20250115587-A1 PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2025-04-10 US disclosed
US-12234227-B2 Pyrazole derivatives as H4 antagonist compounds NXERA PHARMA UK LIMITED (GB) 2025-02-25 US disclosed
EP-4491628-A1 METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT Nihon Medi-Physics Co., Ltd. (JP) 2025-01-15 EP disclosed
WO-2001081347-A2 DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS ABBOTT LABORATORIES (US) 2001-11-01 WO disclosed
WO-2000051609-A1 3-ALKYL SUBSTITUTED PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
US-4727073-A CEREBOVASCULAR DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-02-23 US disclosed
US-4698340-A TREATMENT OF CEREBROVASCULAR DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-10-06 US disclosed
EP-0177287-A2 Pyrimidine derivatives, processes for preparation thereof and composition of the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-09 EP disclosed
EP-0169712-A2 New pyrimidine derivatives, processes for preparation thereof and composition containing the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-29 EP disclosed